Myocardial Infarction (Heart Attack)

Overview

Myocardial infarction (MI), commonly known as a heart attack, is a life-threatening condition characterized by myocardial cell death due to prolonged myocardial ischemia. It represents the most severe manifestation of coronary artery disease and requires immediate medical intervention.

Global Burden: Acute myocardial infarction affects approximately 7.5 million people worldwide annually. In the United States, someone has a heart attack every 40 seconds. Despite advances in treatment, MI remains the leading cause of death globally, with mortality rates of 5-6% for STEMI and 3-5% for NSTEMI in hospitalized patients.

Classification & Types

Fourth Universal Definition of MI (2018):

Type	Definition	Mechanism	Frequency
Type 1	Spontaneous MI due to atherosclerotic plaque rupture/erosion	Primary coronary event	60-70%
Type 2	MI secondary to ischemic imbalance	Supply-demand mismatch	15-20%
Type 3	Sudden cardiac death with symptoms of ischemia	Fatal before biomarker availability	5-10%
Type 4	MI associated with PCI	Procedure-related	5-10%
Type 5	MI associated with CABG	Surgery-related	3-5%

Clinical Classification:

Category	ECG Findings	Troponin	In-hospital Mortality
STEMI	ST elevation in ≥2 contiguous leads	Elevated	5-8%
NSTEMI	ST depression, T-wave inversion, or normal	Elevated	3-5%

Pathophysiology

Sequence of Myocardial Necrosis:

Coronary Occlusion: Plaque rupture with thrombus formation
Ischemia Onset: Cessation of oxygen delivery to myocardium
Anaerobic Metabolism: Switch to inefficient energy production
Cellular Dysfunction: Ion pump failure, calcium overload
Membrane Disruption: Loss of cellular integrity
Necrosis Completion: Irreversible cell death within 20-40 minutes

Temporal Evolution of MI:

Time After Onset	Pathological Changes	Clinical Correlation	Therapeutic Window
0-20 min	Reversible ischemia	Angina, no ECG changes	Complete recovery possible
20 min - 6 hours	Wavefront necrosis	ST elevation, biomarker rise	Reperfusion benefit maximal
6-24 hours	Coagulation necrosis	Q waves develop	Some salvage possible
1-7 days	Inflammation, repair	Fever, CRP elevation	Prevention of complications
1-6 weeks	Scar formation	Remodeling, aneurysm risk	Prevention of remodeling

Clinical Presentation

Classic Symptoms:

Chest Pain: Severe, crushing substernal pain radiating to arms, neck, jaw
Duration: >20 minutes, not relieved by rest or nitroglycerin
Associated Symptoms: Diaphoresis, nausea, vomiting, dyspnea
Autonomic Symptoms: Pallor, cool extremities, tachycardia/bradycardia

Atypical Presentations (More Common in):

Population	Atypical Symptoms	Frequency	Clinical Implications
Diabetics	Silent MI, dyspnea only, fatigue	30-40%	Delayed diagnosis, worse outcomes
Elderly	Confusion, syncope, weakness	40-50%	Higher mortality, more complications
Women	Fatigue, indigestion, back pain	35-45%	Under-recognition, treatment delays
Post-operative	Hypotension, arrhythmias only	20-30%	Diagnostic challenge, high mortality

Cardiac Arrest Warning Signs: Sudden collapse, unresponsiveness, no normal breathing, no pulse. Immediate CPR and defibrillation required. Survival decreases 7-10% per minute without intervention.

Diagnosis & Investigations

Diagnostic Criteria (Universal Definition):

Clinical: Symptoms of myocardial ischemia
ECG: New ST-T changes or pathological Q waves
Biomarkers: Rise and/or fall of cardiac troponin with at least one value above 99th percentile URL
Imaging: New loss of viable myocardium or regional wall motion abnormality

Cardiac Biomarker Kinetics:

Biomarker	Initial Rise	Peak	Normalization	Sensitivity/Specificity
High-sensitivity Troponin	2-3 hours	12-24 hours	5-10 days	95%/90%
CK-MB	4-6 hours	18-24 hours	48-72 hours	85%/95%
Myoglobin	1-2 hours	6-9 hours	24 hours	90%/70%

ECG Localization of STEMI:

Infarct Location	ECG Changes	Culprit Artery	Complications
Anterior	V1-V4	LAD	Heart failure, cardiogenic shock
Inferior	II, III, aVF	RCA (80%), LCx (20%)	Bradycardia, RV infarction
Lateral	I, aVL, V5-V6	LCx, diagonal	Mitral regurgitation
Posterior	Tall R V1-V2, ST depression	RCA, LCx	High mortality if missed

Acute Management

STEMI Reperfusion Strategy:

Strategy	Door-to-Balloon Time	Door-to-Needle Time	Mortality Reduction
Primary PCI	<90 minutes	N/A	40-50% vs conservative
Fibrinolysis	N/A	<30 minutes	25-30% vs placebo
Pharmaco-invasive	3-24 hours	<30 minutes	35-40% vs fibrinolysis alone

Immediate Medical Therapy (First 24 hours):

Medication	STEMI Dose	NSTEMI Dose	Contraindications
Aspirin	162-325 mg chewed	162-325 mg chewed	Active bleeding, anaphylaxis
P2Y12 Inhibitor	Loading dose pre-PCI	Loading dose	Major bleeding, CABG planned
Anticoagulant	UFH/enoxaparin	UFH/enoxaparin/fondaparinux	Active bleeding, HIT
Beta-blocker	Oral if stable	Oral if stable	Shock, pulmonary edema, Bradycardia
Statin	High-intensity immediately	High-intensity immediately	Active liver disease

Ayurvedic Treatment

Ayurvedic Perspective:

Myocardial infarction is understood as Hridya Dhamani Pratichaya (coronary obstruction) leading to Hridshotha (heart inflammation) and Hridkathinya (myocardial necrosis). It represents acute Vata and Pitta vitiation with Rakta and Meda Dushti affecting Rasavaha and Raktavaha Srotas.

Emergency Herbal Interventions:

Arjuna Kwath: Immediate cardiotonic and anti-ischemic decoction
Hridayarnava Rasa: Emergency formulation for acute cardiac crisis
Punarnavadi Guggulu: For congestion and fluid overload
Sarpagandha Ghan Vati: For hypertension and sympathetic storm
Lasunadi Vati: Garlic-based antiplatelet and fibrinolytic

Single Herbs for Acute MI Management:

Herb	Sanskrit Name	Emergency Protocol	Mechanism of Action
Arjuna	Arjuna (Terminalia arjuna)	5g bark decoction every 2 hours initially	Cardioprotective, anti-ischemic, antioxidant, inotropic
Guggulu	Guggulu (Commiphora mukul)	High dose for plaque stabilization and anti-inflammatory	Lowers cholesterol, reduces platelet aggregation, anti-inflammatory
Garlic	Laśuna (Allium sativum)	Fresh paste 5g every 6 hours or high-potency extract	Antiplatelet, fibrinolytic, vasodilator, lipid-lowering
Turmeric	Haridrā (Curcuma longa)	High-dose curcumin with black pepper	Powerful anti-inflammatory, antioxidant, endothelial protection
Ginger	Ārdraka (Zingiber officinale)	Fresh juice 10ml with honey every 4 hours	Antiplatelet, anti-inflammatory, improves circulation
Ashwagandha	Aśvagandhā (Withania somnifera)	For stress-induced MI and recovery phase	Adaptogen, reduces cortisol, cardioprotective
Brahmi	Brahmi (Bacopa monnieri)	For anxiety and sympathetic overactivity	Anxiolytic, neuroprotective, reduces stress response

Ayurvedic Emergency Procedures:

Hrid Basti (Emergency): Localized warm oil therapy
- Medicated oils: Mahanarayan, Dhanwantaram, Brahmi
- Duration: 15-20 minutes during acute phase
- Frequency: 2-3 times daily initially
- Mechanism: Improves coronary circulation, reduces pain, prevents arrhythmias
Shirodhara (Modified): For autonomic stabilization
- Cooling oils for Pitta predominance (Brahmi, coconut)
- Warm oils for Vata predominance (sesame, Mahanarayan)
- Short duration: 10-15 minutes
- Reduces sympathetic overactivity and anxiety
Pranayama (Emergency): Breathing techniques for acute phase
- Sheetali and Sheetkari: Cooling, calming during pain
- Anulom Vilom: Balancing autonomic nervous system
- Bhramari: Reduces anxiety and sympathetic tone
- Contraindicated during active chest pain
Virechana (Post-stabilization): Therapeutic purgation
- After 2-3 weeks when patient stabilized
- Removes metabolic toxins and excess Pitta
- Reduces inflammation and thrombotic tendency
- Contraindicated in acute phase and unstable patients

Dietary Management (Acute Phase):

Immediate Dietary Protocol (First 72 hours):
- Liquid diet: Arjuna kwath, ginger tea, vegetable soups
- Small quantities every 2-3 hours
- Complete avoidance of heavy, fried, processed foods
- Warm water sipping throughout the day
Specific Emergency Nutrition:
- Arjuna bark decoction: 5g in 200ml water, reduced to 3g after 24 hours
- Garlic soup: 3-4 cloves boiled with ginger and turmeric
- Pomegranate juice: Fresh, without sugar, for antioxidants
- Coriander seed water: Soaked overnight, anti-inflammatory
Foods to Strictly Avoid:
- Red meat and processed meats
- Fried foods and trans fats
- Excess salt and sugar
- Refined carbohydrates
- Caffeine and stimulants
- Alcohol and tobacco
- Cold drinks and ice cream

Lifestyle Modifications (Acute Phase):

Immediate Rest Protocol:
- Complete bed rest for first 72 hours
- Semi-Fowler's position (30-45 degree head elevation)
- Strict avoidance of physical exertion
- Gradual mobilization after 3 days if stable
Stress Management:
- Complete mental rest, avoid emotional triggers
- Meditation and mindfulness techniques
- Soothing music and positive environment
- Family support and counseling
Monitoring Parameters:
- Regular pulse monitoring (rate and rhythm)
- Respiratory rate and pattern
- Symptom diary for chest pain recurrence
- Blood pressure monitoring

Ayurvedic Emergency Strategy for MI: Immediate approach focuses on Vatanulomana (Vata pacification) to relieve pain and spasm, Pittashamana (Pitta reduction) to reduce inflammation and thrombotic tendency, Kaphahara (Kapha balancing) to clear obstruction, Raktashodhana (blood purification) to improve microcirculation, and Hridya Rasayana (cardiac rejuvenation) for myocardial protection and repair. Integration with conventional emergency care is absolutely essential.

Complications

Acute Complications (First 48 hours):

Complication	Frequency	Risk Factors	Management
Arrhythmias	80-90%	Anterior MI, large infarct	Antiarrhythmics, cardioversion
Heart Failure	20-30%	Anterior MI, multivessel disease	Diuretics, afterload reduction
Cardiogenic Shock	5-8%	Large infarct, elderly, diabetes	Inotropes, mechanical support
Mechanical Complications	1-3%	First MI, no collaterals, late presentation	Emergency surgery

Killip Classification of Heart Failure in MI:

Class	Clinical Features	Mortality	Management
Class I	No heart failure	6%	Standard therapy
Class II	Rales, S3 gallop	17%	Diuretics, afterload reduction
Class III	Pulmonary edema	38%	Aggressive diuresis, possible intubation
Class IV	Cardiogenic shock	67%	Inotropes, mechanical support, urgent revascularization

Prognosis & Risk Stratification

Short-term Mortality Predictors:

Risk Factor	Odds Ratio for Mortality	Clinical Implications
Cardiogenic Shock	8.5	Immediate invasive strategy
Age >75 years	4.2	Individualized approach
Anterior MI	3.1	Aggressive management
Heart Rate >100 bpm	2.5	Beta-blocker caution
Killip Class II-IV	2.4	Close monitoring needed

Long-term Outcomes:

Time Period	Mortality	Reinfarction	Heart Failure
30 days	6-8%	3-4%	8-10%
1 year	10-12%	6-8%	15-18%
5 years	20-25%	12-15%	25-30%
10 years	35-40%	18-22%	40-45%

Secondary Prevention

Lifelong Medical Therapy:

Medication	Target	Benefit	Duration
Dual Antiplatelet	Prevention of stent thrombosis	30-40% event reduction	6-12 months
High-intensity Statin	LDL <70 mg/dL	35% event reduction	Lifelong
Beta-blocker	Heart rate 55-60 bpm	25% mortality reduction	Lifelong
ACE Inhibitor	BP <130/80 mmHg	20% event reduction	Lifelong

Cardiac Rehabilitation Critical Components: Supervised exercise training, risk factor modification, psychosocial support, nutritional counseling, medication adherence education. Participation reduces mortality by 20-25% and improves quality of life.

Special Considerations

MI in Specific Populations:

Population	Special Features	Management Considerations
Women	Atypical symptoms, microvascular disease, later presentation	Higher suspicion, consider non-obstructive CAD
Diabetics	Silent MI, multivessel disease, worse outcomes	More aggressive risk factor control
Elderly	Atypical presentation, comorbidities, frailty	Individualized approach, consider functional status
Chronic Kidney Disease	Atypical biomarkers, contrast nephropathy risk	Careful medication dosing, consider non-contrast options

Mechanical Complications (Surgical Emergencies): Ventricular septal rupture, free wall rupture, papillary muscle rupture. Present with sudden hemodynamic deterioration, new murmur, or electromechanical dissociation. Require immediate surgical consultation and intervention.